Diagnostics & Imaging
Cleerly LABS and Cleerly PLAQUE
Coronary CT plaque analysis with an FDA-cleared Cleerly LABS update announced October 30, 2026.
The Signal
Cleerly reports the updated PLAQUE algorithm uses CONFIRM2 registry data from 6,550 people across 46 countries, approximately 50% female. The company expects availability in November 2026; clearance and availability are distinct.
Company profileMore in Diagnostics & Imaging
Aidoc
AI software that flags acute abnormalities on medical scans to prioritize radiologist workflows.
View toolViz.ai
AI platform that detects time sensitive emergencies like strokes and coordinates care across hospital networks.
View toolLunit
AI tools that assist clinicians in detecting cancer on mammograms and chest X-rays.
View toolPaige AI
AI based digital pathology software that assists pathologists in detecting prostate and breast cancers.
View tooliRhythm
Ambulatory electrocardiogram monitoring service using wearable patches and AI to analyze cardiac rhythms.
View toolHeartFlow
Software creating personalized three dimensional models of coronary arteries to analyze blood flow.
View tool